MSLN and mesothelioma: One intriguing study in which 11 mesothelioma patients who received preconditioning with cyclophosphamide followed by a single dose of mesothelin targeted CAR-T cells and at least three doses of anti-PD-1agent resulted in a 72% response rate and complete metabolic responses in two patients75.